IHS Chemical Week

Chemical Week Magazine :: Business & Finance :: United States/Americas

Genomatica Files for IPO to Fund Biobased BDO, Butadiene

5:55 AM MDT | August 26, 2011 | —REBECCA COONS

Genomatica (San Diego), a developer of biobased chemicals, has filed with the SEC for an initial public offering (IPO) worth up to $100 million. The number of shares offered and the price range of the offering have not been determined. Founded in 2000, the company has built momentum behind its 1,4-butanediol (BDO) process in recent months, signing joint venture deals with Mitsubishi Chemical and Novamont (Novara, Italy). The company also announced last week that its second commercial target will be biobased butadiene. Genomatica has intellectual property covering...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa